S. Memon

发表

Projected effect of fecal immunochemical test threshold for colorectal cancer screening on outcomes and costs for Canada using the OncoSim microsimulation model

C. Earle, A. Miller, M. Wolfson, 2017 .

Estimates of future cancer mortality attributable to modifiable risk factors in Canada

C. Friedenreich, D. Brenner, P. Villeneuve, 2021, Canadian Journal of Public Health.

Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in Canada.

A. Miller, M. Wolfson, A. Coldman, 2016, Current oncology.

OA 06.01 Costs and Cost-Effectiveness of Smoking Cessation Within an Organized CT Lung Cancer (LC) Screening Program

A. Miller, J. Goffin, W. Flanagan, 2017 .

OA17.02 Potential Health and Economic Consequences of Organized vs Opportunistic Lung Cancer Screening in Canada

A. Miller, M. Wolfson, J. Goffin, 2017 .

Comparing the health and economic impacts of cervical cancer screening strategies using the Cancer Risk Management Model (CRMM)

G. Lockwood, A. Miller, A. Coldman, 2016 .

Moving toward the elimination of cervical cancer: modelling the health and economic benefits of increasing uptake of human papillomavirus vaccines.

C. Earle, N. Fitzgerald, S. Memon, 2019, Current oncology.

Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model.

A. Miller, M. Wolfson, J. Goffin, 2020, CMAJ open.

Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness.

A. Miller, M. Wolfson, J. Goffin, 2016, Lung cancer.

Cost-effectiveness of Lung Cancer Screening in Canada.

A. Miller, M. Wolfson, J. Goffin, 2015, JAMA oncology.

Water Stress Tolerance in Relation to Yield and its Contributing Traits in Wheat (Triticumaestivum L.)

P. A. Shar, S. Memon, A. H. Shar, 2014 .

BIOMETRICAL ANALYSIS OF SOME QUANTITATIVE TRAITS OF COTTON (GOSSYPIUMHIRSUTUM L.)

A. Shar, P. A. Shar, S. Memon, 2014 .

The OncoSim model: development and use for better decision-making in Canadian cancer control.

A. Miller, A. Coldman, W. Flanagan, 2017, Current oncology.

Simulating results from trials of sigmoidoscopy screening using the OncoSim microsimulation model

C. Earle, A. Miller, M. Wolfson, 2017 .

Estimating the future cancer management costs attributable to modifiable risk factors in Canada

C. Friedenreich, D. Brenner, S. Walter, 2021, Canadian Journal of Public Health.

Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and duration.

J. Goffin, W. Flanagan, N. Fitzgerald, 2016, Current oncology.